June 1, 2026 · Form 4 insider transaction
Napolitano Janet sold 3,200 shares of Vir Biotechnology, Inc. at $9.45 per share, a transaction worth $30.2K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 27, 2025.